Potentiation by heparin fragment CY 222 (Choay) of thrombolysis induced by human tissue-type plasminogen activator.
Juhan-Vague
I
I
University Hospital Timone, Marseille, France.
Stassen
J M
JM
Alessi
M C
MC
Elias
A
A
Aillaud
M F
MF
Serradimigni
A
A
Collen
D
D
D000818:Animals; D004341:Drug Evaluation; D004357:Drug Synergism; D004730:Endothelium, Vascular / Q000378:metabolism; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010314:Partial Thromboplastin Time; D010960:Plasminogen Activators / Q000494:pharmacology; D011817:Rabbits; D011897:Random Allocation; D013924:Thrombophlebitis / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000494:pharmacology / Q000502:physiology*; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology
D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator